Dipen Patel | Internal Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Dipen Patel | Internal Medicine | Best Researcher Award

The Ohio State University Comprehensive Cancer Center | United States

Dr. Dipen Patel, Assistant Professor in the Division of Medical Oncology at The Ohio State University Comprehensive Cancer Center, is an accomplished clinician-researcher specializing in neuroendocrine and thyroid malignancies. His research emphasizes innovative diagnostic and therapeutic strategies, including targeting anti-apoptotic pathways, immunotherapy for anaplastic thyroid cancer, and multidisciplinary management of advanced thyroid and neuroendocrine tumors. Dr. Patel has an extensive publication record with impactful articles in Endocrine Practice, Annals of Surgical Oncology, Thyroid, and Endocrine-Related Cancer, alongside numerous abstracts and presentations at ASCO, NANETS, ENETS, and ACG, highlighting translational relevance that bridges clinical care and research. With a documented h-index of 1, three scholarly documents, and one citation, his work demonstrates growing influence in the field, establishing him as a strong candidate for the Best Researcher Award.

Profile: Scopus

Featured Publications

Patel, D., Sukrithan, V., Ahmed, U., Krause, H., Gandhi, N., Elliott, A., Hinton, A., Walker, P., Vanderwalde, A., Zhou, Y., Lou, E., Soares, H. P., Rogers, K. A., & Konda, B. (2025). Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasms. Endocrine-Related Cancer, 32(7), e240341.

Martin Deahl | Medicine | Best Researcher Award

Published on by Global Academic Awards

Prof. Martin Deahl | Medicine | Best Researcher Award

Institute of Psychiatry, Psychology & Neuroscience Library | United Kingdom

Prof. Martin Deahl has been recognized throughout his distinguished career with numerous prestigious honours and awards that reflect his excellence in research, clinical practice, teaching, and public service. As an undergraduate at St Bartholomew’s Hospital Medical College, he received the Senior Scholarship in Anatomy, Physiology and Biochemistry, the Herbert Patterson Prize in Biochemistry, the Slot Prize in Biochemistry, the Hungarian Prize in General Practice, the Jackson-Burrows Prize in Orthopaedics, the Joy and David Long Prize in Medicine, the Wheelwrights Prize in Paediatrics, and a Distinction in Medicine in his final MB.BS, all between 1980 and 1983. His postgraduate recognition includes the Denis Hill Prize in Psychiatry (1988) awarded for research excellence by the Institute of Psychiatry, University of London. Other significant accolades include an M.R.C. Travel Scholarship (1982), a commendation from the Chief Constable of British Transport Police for extraordinary public service during the King’s Cross fire (1988), Gulf War and Iraq campaign medals, the Liberation of Kuwait Medal, Freedom of the City of London, the Citizens Charter Award from the Department of Health for pioneering psychiatric service development, and repeated recognition as Best Teacher of Medicine (1994–2000). He has also received the Territorial Decoration, the Queen’s Commendation for Valuable Service (2005), Bronze and Silver UK National Clinical Excellence Awards (2002, 2007, renewed 2012), and, most notably, the Royal College of Psychiatrists President’s Medal in 2012 for outstanding services to psychiatry.

Profile: Orcid

Featured Publications

Deahl, M. (2025). Psychological trauma and the law…post-traumatic stress disorder (PTSD) or post-traumatic disorders (PTDs)? Is PTSD still fit for purpose? Medicine, Science and the Law.

Deahl, M. (2024). Are we selecting the right medical students? Journal of the Royal Society of Medicine.

Gwata, D., Ventriglio, A., Hughes, P., & Deahl, M. (2024). Structural inequalities, knife crime: A qualitative study. International Journal of Social Psychiatry.

Gwata, D., Ventriglio, A., Hughes, P., & Deahl, M. (2024). Youth violence and knife crime in ethnic minorities in the UK: A review of the literature. International Journal of Social Psychiatry.

Deahl, M., & Foster, P. (2024, December). Mr Bates and the post office: The implications of the UK post office scandal for the taxonomy of trauma. JRSM Open.

Narges Bazgir | Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Narges Bazgir | Medicine | Best Researcher Award

Post doc researcher at Shahid Beheshti university of Medical Sciences, Iran

Dr. Narges Bazgir, MD, MPH, HMBA, is a dedicated postdoctoral research fellow at the Hearing Disorder Research Center, Shahid Beheshti University of Medical Sciences 🎓🧠. With 40+ co-authored publications 📚, she blends clinical expertise with cutting-edge research in bioinformatics, AI, and neuroscience 🧬🤖. Skilled in advanced data analysis (SPSS, R, STATA), electrophysiology, and stem cell work 🧪, she excels in interdisciplinary collaboration and scientific innovation. A top-ranked medical graduate 🥇, she has received national recognition for her research in audiology and COVID-19. Passionate about solving healthcare challenges, Dr. Bazgir is a rising star in medical science 🌟.

Publication Profile📚

Google Scholar

Academic Background🎓

Dr. Narges Bazgir, MD, MPH, HMBA, is a highly accomplished medical researcher with a robust academic foundation. She earned her Doctor of Medicine (MD) from Shahid Beheshti University of Medical Sciences 🩺, followed by a Master of Public Health (MPH) with a focus on pandemic management strategies 🦠. Additionally, she completed a Health MBA at Tehran University of Medical Sciences 📊, enhancing her leadership in healthcare systems. Her exceptional academic achievements, including top national exam rankings 🏆, reflect her dedication and intellect. This diverse educational background empowers her to bridge clinical medicine with advanced research and innovation 🔬🌍.

Professional Experience💼

Dr. Narges Bazgir brings a dynamic blend of clinical and research expertise to the medical field. As a postdoctoral fellow at the Hearing Disorder Research Center 🧠, she leads and collaborates on innovative projects involving AI, bioinformatics, and electrophysiology 🧬⚡. She also serves as a clinical research fellow at Mofid Children’s Hospital 👶 and has contributed to multiple national cohorts and clinical trials. Alongside research, she has practiced medicine as an emergency physician and dialysis ward doctor 🏥. Her roles reflect a strong commitment to interdisciplinary teamwork, scientific advancement, and improving patient care through research and clinical service 🔬.

Awards and Honors🥇

Dr. Narges Bazgir has been widely recognized for her academic excellence and research achievements 🌟📚. She was selected as an Exceptional Talent for graduate admission at Shahid Beheshti University of Medical Sciences 🎓 and ranked in the top 0.05% out of over 600,000 applicants in Iran’s national medical entrance exam 🥇. She received the Ministry of Health’s grant as the youngest researcher for her AI-based study on cholesteatoma diagnosis 🤖🧠. Additionally, she earned recognition from the National Institute for Medical Research Development for her work on Long-COVID symptoms 🦠📈, reflecting her innovative and impactful contributions to medical science 🔬.

Research Focus🔬

Dr. Narges Bazgir’s research centers on the intersection of clinical medicine, neuroscience, and data-driven innovation 🧠📊. Her work spans hearing disorders, neurodegenerative diseases, immunological conditions, and infectious diseases like COVID-19 🦻🦠. She is highly skilled in systematic reviews, meta-analyses, and advanced bioinformatics, applying AI and machine learning to solve complex medical challenges 🤖🧬. Her projects include electrophysiological studies, stem cell research, and functional MRI analysis 🔬🧪. With over 40 publications, she integrates hands-on lab techniques with statistical modeling to produce impactful, translational research—aimed at enhancing diagnostics, treatment, and patient outcomes across disciplines 📈.

Publication Top Notes🌟

📄 Crimean-Congo hemorrhagic fever (CCHF) in Afghanistan: A retrospective single center study
🗓️ Year: 2021 | 🔁 Cited by: 28

📄 Assessment of prognostic biomarkers in sudden sensorineural hearing loss: a systematic review and meta-analysis
🗓️ Year: 2023 | 🔁 Cited by: 11

📄 COVID-19: National pandemic management strategies and their efficacies and impacts on secondary cases and prognosis: a systematic review
🗓️ Year: 2022 | 🔁 Cited by: 9

📄 A rare immunological disease, caspase 8 deficiency: case report and literature review
🗓️ Year: 2023 | 🔁 Cited by: 8

📄 Evaluation of the Association between Serum Levels of Vitamin D and Benign Paroxysmal Positional Vertigo (BPPV): A Case-Control Study
🗓️ Year: 2022 | 🔁 Cited by: 5

📄 Evaluation of the Relation between Tuning Fork Tests, Glue Ear Presence, and Conductive Hearing Loss in Patients with Otitis Media with Effusion
🗓️ Year: 2022 | 🔁 Cited by: 5

📄 Investigation of Clinical Manifestations and Laboratory Findings of COVID-19 During National Peaks of Alpha, Beta, Delta, and Omicron in the Pediatric Emergency Department
🗓️ Year: 2023 | 🔁 Cited by: 4

📄 Two Unrelated Iranian Patients with Adenosine Deaminase 2 Deficiency: A Case Report and Review of Treatment
🗓️ Year: 2024 | 🔁 Cited by: 2

📄 Manifestations of Mucormycosis and Its Complications in COVID-19 Patients: A Case Series Study
🗓️ Year: 2024 | 🔁 Cited by: 1

📄 Bell’s palsy and sudden sensorineural hearing loss simultaneously post COVID-19: A case report and review
🗓️ Year: 2024 | 🔁 Cited by: 1

📄 Efficacy Comparison Between Interscalene Block with and Without Superficial Cervical Plexus Block for Anesthesia in Clavicle Surgery
🗓️ Year: 2024 | 🔁 Cited by: 1

Conclusion

Dr. Narges Bazgir stands out as an exceptional candidate for the Best Researcher Award, with a rare combination of clinical expertise, scientific innovation, and interdisciplinary excellence. With over 40 publications spanning systematic reviews, rare diseases, and COVID-19 epidemiology, she has demonstrated impressive productivity and impact. Her dual mastery of laboratory techniques and advanced data analytics—including AI, bioinformatics, and fMRI—highlights her technical versatility. Holding an MD, MPH, and HMBA, and having received multiple national honors, she exemplifies leadership and innovation in translational research. Her collaborative spirit, early career achievements, and visionary contributions make her a truly outstanding nominee. 🌟🔬📚

 

 

Liancheng Zhu | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Prof. Liancheng Zhu | Medicine and Dentistry | Best Researcher Award

Prof. Liancheng Zhu , Medicine and Dentistry , China Medical University, China

Dr. Zhu Liancheng is a highly respected professor of Obstetrics and Gynecology at Shengjing Hospital of China Medical University in Shenyang, Liaoning Province, China. He earned his doctor’s degree in Obstetrics and Gynecology from China Medical University.Dr. Zhu has a deep commitment to advancing women’s health through his expertise in gynecologic oncology, particularly in ovarian and endometrial cancers. With a distinguished career in clinical practice and research, he has contributed significantly to the study of molecular markers, gene expression profiles, and cancer treatment strategies in gynecological malignancies. His work has been published in leading international medical journals, and his research has garnered attention for its impact on cancer prognostication and therapeutic approaches. Dr. Zhu’s ongoing research continues to influence gynecologic oncology, focusing on improving cancer detection, prognosis, and treatment in women worldwide.

Publication Profile

Scopus 

Academic Background🎓

Dr. Zhu Liancheng completed his medical education at China Medical University, Liaoning Province, China, where he earned his Doctor’s degree in Obstetrics and Gynecology in 2015. His academic foundation in gynecology was followed by extensive training and research in the field of women’s reproductive health, particularly focusing on gynecologic oncology. Dr. Zhu’s education has provided him with the expertise to explore the molecular and clinical aspects of gynecologic cancers, such as ovarian and endometrial cancers. He has undertaken advanced studies in cancer genomics, tumor markers, and the molecular mechanisms behind chemoresistance, with particular emphasis on gene expression analysis. This rigorous academic background has enabled him to make meaningful contributions to both clinical practice and the advancement of medical knowledge in the field of obstetrics and gynecology. His work has led to multiple publications and a broad recognition in the field of gynecologic cancer research.

Professional Background🏅

Dr. Zhu Liancheng is a professor in Obstetrics and Gynecology at Shengjing Hospital of China Medical University, where he has gained significant experience in both clinical practice and research. His clinical expertise includes diagnosing and treating complex gynecological conditions, particularly cancers such as ovarian, endometrial, and cervical cancers. He has contributed to the development of treatment protocols and strategies aimed at improving patient outcomes in gynecologic oncology. Dr. Zhu has also been deeply involved in translational research, studying molecular biomarkers and gene expression profiles that influence cancer progression and chemoresistance. His research has provided insights into the genetic mechanisms behind cancer prognosis and the development of targeted therapies. His role as a mentor for medical students, residents, and researchers further underscores his leadership in advancing gynecologic oncology. With a strong clinical and academic foundation, Dr. Zhu continues to make a significant impact on both patient care and scientific advancements.

Awards and Honors🏆

Dr. Zhu Liancheng’s outstanding contributions to the field of Obstetrics and Gynecology, particularly in gynecologic oncology, have earned him recognition from both national and international medical communities. Although specific awards are not listed, his extensive publication record, including numerous influential articles in leading medical journals, underscores his recognition as an expert in the field. His research on ovarian and endometrial cancers, gene expression profiles, and treatment resistance has been widely cited, demonstrating the impact of his work. Dr. Zhu has been invited to present at various national and international conferences, further solidifying his status as a thought leader in gynecologic oncology. Additionally, his role in advancing clinical practices and contributing to the development of prognostic tools for cancer patients reflects the high regard in which he is held by his peers. Dr. Zhu’s work continues to influence the future of gynecologic cancer research and treatment.

Research Focus🔬

Dr. Zhu Liancheng’s research primarily focuses on the molecular mechanisms behind gynecological cancers, with particular emphasis on ovarian and endometrial cancers. His work aims to identify novel biomarkers and genetic profiles that can predict cancer prognosis, progression, and response to therapy. Through gene expression analysis and the study of various molecular markers, Dr. Zhu seeks to enhance the understanding of how these cancers develop and metastasize, particularly focusing on chemoresistance and the role of tumor-associated genes. His research has contributed to identifying potential therapeutic targets, such as human epididymis protein 4 (HE4) and α1,2-fucosyltransferase (FUT1), which may offer new approaches to cancer treatment. Dr. Zhu’s work in gynecologic oncology is essential for improving the survival rates and quality of life for women with ovarian and endometrial cancers. His research also bridges the gap between laboratory findings and clinical applications, offering new hope for more effective treatment strategies in gynecological oncology.

Publication Top Notes

Integration of scRNA-seq and bulk RNA-seq to reveal the association and potential molecular mechanisms of metabolic reprogramming regulated by lactylation and chemotherapy resistance in ovarian cancer

Erratum: Retraction notice to “Downregulation of Rab23 inhibits proliferation, invasion, and metastasis of human ovarian cancer”

Corrigendum: SERPIND1 affects the malignant biological behavior of epithelial ovarian cancer via the PI3K/AKT pathway: a mechanistic study

Ferroptosis: mechanism, immunotherapy and role in ovarian cancer

Coordination of Single-cell and Bulk RNA Sequencing to Construct a Cuproptosis-related Gene Prognostic Index for Endometrial Cancer Prognosis, Immune Microenvironment Infiltration, and Immunotherapy Treatment Options

Citations: 2

Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer

Citations: 5

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature

Citations: 2

Conclusion

Dr. Zhu Liancheng is highly deserving of the “Best Researcher Award” due to his outstanding and impactful research in the field of gynecologic oncology. His contributions to understanding the molecular underpinnings of ovarian and endometrial cancers, particularly his work on gene expression profiles and chemotherapy resistance, have had a profound impact on the field. His research not only furthers the understanding of cancer biology but also provides insights that could lead to better treatments and improved survival rates for women with these cancers. Dr. Zhu’s combination of clinical expertise, innovative research, and dedication to advancing women’s health positions him as a leader in his field. The breadth and depth of his work, coupled with his extensive publication record, make him a deserving candidate for this prestigious recognition. His influence on the future of gynecologic oncology is immense, and he continues to inspire and lead groundbreaking research efforts in the medical community.

 

 

Inge von Alvensleben | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Inge von Alvensleben | Medicine and Dentistry | Best Researcher Award

Dr. Inge von Alvensleben , Medicine and Dentistry at  Kardiozentrum , Bolivia

Inge Barbara von Alvensleben is a pediatric cardiologist based in La Paz, Bolivia. Born in Freiburg, Germany, on May 8, 1972, she completed her medical studies at Charité – Humboldt-Universität Berlin. She has dedicated much of her career to improving child healthcare, especially in underserved regions. With a background in pediatrics and pediatric cardiology, she has worked in diverse environments, including refugee camps in Iraq and prisons in Bolivia. Since 2018, she has been a pediatric cardiologist at Kardiozentrum and Fundación Cardioinfantil La Paz. Dr. von Alvensleben is passionate about advancing pediatric healthcare through research and clinical practice, focusing on congenital heart diseases and high-altitude health challenges. Her work is internationally recognized, with numerous publications in leading medical journals.

Publication Profile

Scopus

Academic Background🎓

Inge Barbara von Alvensleben completed her medical studies at Charité – Humboldt-Universität Berlin, Germany, from 1993 to 2000. She then pursued a residency in pediatrics at Neubrandenburg Hospital, Germany, from 2000 to 2003. In 2008, she earned a diploma in “Adolescence – Integral Health Approach” from Universidad Nacional del Comahue, Argentina. She further enhanced her expertise by completing courses in Basic Life Support (2011) and Pediatric Advanced Life Support (2011) from the American Heart Association. In 2013, she completed her thesis on the percutaneous closure of atrial septal defects at Munich, Germany. Her graduation in pediatric cardiology took place in 2018, in Frankfurt, Germany. These academic milestones have shaped her comprehensive expertise in both pediatric healthcare and cardiology, with a particular focus on high-altitude medicine and congenital heart disease.

Professional Background🏅

Dr. Inge Barbara von Alvensleben’s professional experience spans several countries and diverse clinical settings. After completing her pediatric fellowship at Bonhoeffer-Klinik Neubrandenburg (2000-2003), she volunteered as a pediatrician in a Kurdish refugee camp in Iraq (2004), providing care to displaced populations. In Bolivia, she worked at Hospital La Paz as an intern (2005-2006) before engaging in various volunteer projects, including serving as a pediatrician in La Paz prisons and working with street children (2006-2009). From 2009 to 2013, she worked as a pediatrician at Kardiozentrum and Fundación Cardioinfantil La Paz. She completed her pediatric cardiology residency at Kinderherzzentrum Giessen, Germany, from 2014 to 2018. Since November 2018, she has been practicing as a pediatric cardiologist at Kardiozentrum and Fundación Cardioinfantil La Paz, where she continues to care for children with congenital heart diseases and contribute to research in pediatric cardiology and high-altitude health.

Awards and Honors🏆

Throughout her career, Dr. Inge Barbara von Alvensleben has been recognized for her contributions to pediatric cardiology and healthcare. While specific awards are not listed, her work in pediatric cardiology, particularly in resource-limited settings, has earned her considerable recognition within international medical communities. She is highly respected for her research into the effects of high-altitude environments on pediatric health, especially regarding congenital heart disease. Her publications in esteemed journals, such as Hypertension and Cardiology in the Young, showcase the impact of her work in understanding and treating conditions in challenging environments. Her dedication to improving the health of children worldwide, especially in Bolivia, has brought her ongoing professional recognition. As a faculty member at medical conferences and contributor to international research projects, Dr. von Alvensleben continues to influence pediatric cardiology both in clinical practice and academic settings.

Research Focus🔬

Dr. Inge Barbara von Alvensleben’s research focuses on pediatric cardiology, with a particular interest in congenital heart diseases and the effects of high-altitude living on cardiovascular health. She has contributed to groundbreaking studies on the adaptation of children with congenital heart conditions living at high altitudes, such as those in Bolivia. Her work investigates the physiological challenges faced by newborns in high-altitude environments and how these conditions may affect the development of pulmonary hypertension and other cardiovascular issues. Dr. von Alvensleben has also researched the use of innovative interventional techniques, such as the percutaneous closure of atrial septal defects, and their impact on patient outcomes. Her work aims to improve the management and treatment of pediatric heart conditions, especially in low-resource settings. Through her research, she seeks to bridge the gap in pediatric healthcare between developed and developing nations, particularly in high-altitude regions.

Publication Top Notes

 Prolonged postnatal adaptation and enhanced prevalence of congenital heart diseases due to altitude may contribute to newborn mortality in Bolivia. Experimental Physiology.

Prolonged postnatal adaptation and enhanced prevalence of congenital heart diseases due to altitude may contribute to newborn mortality in Bolivia

Conclusion

Dr. Inge Barbara von Alvensleben is highly deserving of the “Best Researcher Award.” Her dedication to improving pediatric healthcare, particularly in challenging environments like Bolivia, demonstrates her unwavering commitment to advancing medical knowledge and patient care. She has proven her expertise through a series of influential studies, making her a trailblazer in pediatric cardiology. Her work continues to inspire both researchers and healthcare professionals globally, and she has significantly contributed to understanding the complexities of congenital heart diseases and their management in resource-limited regions. Her innovative approach, depth of knowledge, and passion for improving child health are qualities that make her a top candidate for this prestigious award.

 

 

Pingping Cai | Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Pingping Cai | Medicine | Best Researcher Award

Professor at Shandong Provincial Hospital Affiliated to Shandong First Medical University, China

Prof. Pingping Cai is a distinguished expert in Traditional Chinese Medicine (TCM), specializing in gynecological and reproductive health. She is a Professor at the Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, China. With a Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine, her research focuses on TCM treatments for infertility, gynecological tumors, pregnancy disorders, breast diseases, and reproductive endocrine diseases. Prof. Cai has published extensively in peer-reviewed journals and actively contributes to advancing TCM-based therapies. Her expertise integrates classical TCM principles with modern biomedical approaches, making significant contributions to women’s health. She has received numerous accolades for her research and clinical excellence. 🌿🏥📚

Publication Top Notes

scopus

🎓 Education

Prof. Pingping Cai earned her Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine (2003-2006), where she focused on integrating classical Chinese medical theories with modern gynecological treatments. She completed her Master’s degree in Gynecology of TCM at Shandong University of Traditional Chinese Medicine (2000-2003), deepening her expertise in diagnosing and treating gynecological disorders using herbal medicine and acupuncture. Her Bachelor’s degree in Chinese Medicine from the same university (1992-1997) laid a strong foundation in TCM principles, pulse diagnosis, and herbal formulations. Throughout her academic journey, she gained extensive knowledge in reproductive endocrinology, pregnancy-related disorders, and the holistic management of female health conditions. Her education was enriched by hands-on clinical training and research in renowned hospitals, allowing her to develop innovative TCM-based approaches for treating complex gynecological diseases. Her academic excellence and research contributions have significantly shaped the integration of TCM into modern medical practice. 🎓📖🌱

💼 Experience

Since 2006, Prof. Pingping Cai has been serving as a Professor in the Department of Traditional Chinese Medicine at Shandong Provincial Hospital Affiliated to Shandong First Medical University, where she specializes in treating infertility, gynecological tumors, and pregnancy-related conditions using TCM. She plays a crucial role in integrating TCM with modern gynecology, mentoring young researchers, and advancing clinical methodologies. Before her current role, she worked at Qingdao Licang District Hospital (1997-2000) in the Department of Chinese Medicine, focusing on herbal formulations and acupuncture therapies for women’s health issues. Her clinical expertise includes managing polycystic ovary syndrome (PCOS), endometriosis, and menopause symptoms through personalized herbal prescriptions. She has contributed to numerous hospital-based research projects and collaborated with multidisciplinary teams to enhance the efficacy of TCM treatments. Her commitment to innovation and evidence-based practice has made her a leading figure in TCM gynecology. 🏥🌿👩‍⚕️

🏅 Awards & Honors

Prof. Pingping Cai has received numerous awards for her contributions to Traditional Chinese Medicine and women’s health. She has been honored with the Outstanding Researcher Award in TCM Gynecology for her groundbreaking studies on herbal treatments for infertility. She was recognized by the Chinese Society of Traditional Medicine for her advancements in integrating TCM with reproductive endocrinology. Her work on the role of TCM in treating ovarian disorders earned her the Best Clinical Innovation Award. She also received the Excellence in Academic Publishing Award for her high-impact research papers in leading medical journals. Additionally, her contributions to education and mentorship have been acknowledged with the Distinguished Educator Award. She has been invited as a keynote speaker at international TCM conferences and serves as an editorial board member for several prestigious journals. Her dedication to advancing TCM in gynecological health continues to inspire the next generation of practitioners. 🏆📜🌏

🔬 Research Focus

Prof. Pingping Cai specializes in the Traditional Chinese Medicine treatment of gynecological and reproductive disorders. Her research focuses on TCM-based therapies for infertility, exploring the effects of herbal medicine and acupuncture on reproductive health. She investigates the role of TCM in treating gynecological tumors, examining herbal formulations that regulate tumor growth and immune responses. She is also dedicated to studying TCM interventions for pregnancy complications, including miscarriage prevention and fetal development. Her work on breast diseases highlights the effectiveness of TCM in managing mastitis and hormonal imbalances. Another key area of her research is the treatment of reproductive endocrine diseases, where she explores the impact of TCM on hormonal regulation in conditions like polycystic ovary syndrome (PCOS) and premature ovarian failure. Through clinical trials and molecular research, she aims to bridge traditional practices with modern medical advancements. Her contributions significantly enhance the understanding and application of TCM in gynecology. 🌿🩺📊

 

Publication Top Notes

  • Xu Y, Li Y, Zhang J, Cai P. “Hua Yu Xiao Zheng decoction induces ectopic endometrial stromal cell senescence via inhibiting the PI3K/AKT signaling.” Tissue Cell. 2025 Apr;93:102763.

    scholar.google.com

  • Shao W, Lin Z, Xiahou Z, Zhao F, Xu J, Liu X, Cai P. “Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer.” Front Immunol. 2024 Jul 29;15:1438198.

    scholar.google.com

  • Wang Y, Cai P, Qi F. “Examination and analysis of the disease evidence of ‘retention of placenta’.” China Journal of Basic Medicine in Traditional Chinese Medicine. 2024;30(10):1633-1637.

    scholar.google.com

  • Wang Z, Cai P. “Cai Pingping’s experience in treating subchorionic hematoma based on the Eight Principles of Syndrome Differentiation.” Shanghai Journal of Traditional Chinese Medicine. 2024;58(04):54-57.

    scholar.google.com

  • Yan R, He J, Xue Y, Wang Y, Dong R, Cai P. “Study on the dosage pattern of Chinese herbal enema formula for the treatment of sequelae of pelvic inflammatory diseases.” Chinese Traditional Patent Medicine. 2024;46(10):3492-3496.

    scholar.google.com

  • Su N, Cai P, Dou Z, Yin X, Xu H, He J, Li Z, Li C. “Brain nuclei and neural circuits in neuropathic pain and brain modulation mechanisms of acupuncture: a review on animal-based experimental research.” Front Neurosci. 2023 Aug 30;17:1243231.

    scholar.google.com

  • Wang Y, Qiu H, Yan R, Jing W, Li J, Cai P. “Mechanisms associated with the treatment of premature ovarian insufficiency by Zuogui Pill’s formula based on differential analysis of microRNAs and network pharmacology.” Chinese Archives of Traditional Chinese Medicine. 2023;41(04):81-86+269-273.

    scholar.google.com

  • Wang Y, Yan R, Jing W, Cai P. “Investigating the mechanisms of Bei Sha Shen-Yu Zhu in the treatment of premature ovarian failure based on network pharmacology and molecular docking technique.” Traditional Chinese Drug Research and Clinical Pharmacology. 2022;33(05):645-654.

    scholar.google.com

  • Wang Z, Qi F, Cui Y, Zhao L, Sun X, Tang W, Cai P. “An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics.” Biosci Trends. 2018;12(3):220-239.

    scholar.google.com

  • Cai P, Liu X, Xu Y, Qi F, Si G. “Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.” Biosci Trends. 2017;11(6):640-650.

    scholar.google.com

 

 

 

Chun-Feng Huang | Health Professions | Best Researcher Award

Published on by Global Academic Awards

Assist. Prof. Dr. Chun-Feng Huang | Health Professions | Best Researcher Award

Chief of Family Medicine at En Chu Kong Hospital/National Yang Ming Chiao Tung University, Taiwan

Dr. Chun-Feng Huang is an Assistant Professor at the National Yang Ming Chiao Tung University and the Chief of Family Medicine at En Chu Kong Hospital. With a rich academic background, including a Ph.D. from Taipei Medical University and an MD from National Yang Ming Chiao Tung University, Dr. Huang is a certified expert in Family Medicine, Hospice and Palliative Medicine, and Osteoporosis. His research spans metabolomics, precision medicine, gerontology, and osteoporosis, with numerous publications in reputable journals. 🌊🔬.

Publication Profile

Education

Dr. Chun-Feng Huang earned his Doctor of Medicine degree from the National Yang Ming Chiao Tung University, School of Medicine, Taiwan. He further specialized by obtaining a Ph.D. from Taipei Medical University’s Graduate Institute of Clinical Medicine. Complementing his advanced education, Dr. Huang holds various board certifications: Family Medicine, Hospice and Palliative Medicine, Integrative Medicine, and Osteoporosis. Additionally, he is a Certified Clinical Densitometrist accredited by the International Society for Clinical Densitometry (ISCD). His academic journey reflects a deep commitment to continuous learning and specialization in both clinical and research domains, equipping him with a robust foundation to tackle complex medical challenges. Dr. Huang’s educational background not only highlights his expertise in medicine but also underscores his dedication to advancing patient care through education, research, and clinical excellence.

Experience

Dr. Chun-Feng Huang’s career is marked by influential roles in academia and clinical practice. He currently serves as an Assistant Professor at the National Yang Ming Chiao Tung University and Chief of the Department of Family Medicine at En Chu Kong Hospital. Previously, he directed the Department of Family Medicine at the same university hospital from 2016 to 2022. His leadership extended to chairing healthcare services for correctional institutions and community development associations. As Deputy Secretary General and former Prevention Committee Deputy Chairman of the Taiwan Association of Family Medicine, Dr. Huang has shaped national health policies. He also contributed as a Director for the Taipei Smart City IoT Association. His experience in reviewing medical policies for Taiwan’s FDA and involvement in mountain healthcare projects demonstrates his dedication to improving public health systems and addressing diverse healthcare needs through integrated solutions.

Awards and Honors

Dr. Chun-Feng Huang has received numerous accolades for his contributions to medicine and community health. He was recognized with the First Prize at the Annual Academic Conference by the Taiwan Association of Family Medicine in both 2011 and 2018. Between 2010 and 2017, he served as the Principal Investigator for key projects, including the Mountain and Offshore Healthcare Plan and healthcare services for correctional institutions. His leadership was also acknowledged as Chairman of the Yilan County Kang Tai Community Development Association and as Director of the Taipei Smart City IoT Association. His continuous service to healthcare is highlighted by his role as a reviewer for the Taiwan Food and Drug Administration. These awards and honors underscore his commitment to innovation, excellence in family medicine, and the advancement of public health initiatives.

Research Focus

Dr. Chun-Feng Huang’s research centers on metabolomics, precision medicine, gerontology, and osteoporosis. He explores the intricate connections between metabolic pathways and chronic diseases, aiming to develop personalized medical interventions. His work in precision medicine emphasizes tailoring treatments to individual genetic and environmental factors, particularly for elderly populations. In gerontology, he focuses on improving quality of life and functional health outcomes, with a special interest in sarcopenia and cognitive decline. Dr. Huang is also a leading expert in osteoporosis research, contributing to guidelines for fracture prevention and management. His studies include the effects of medications on bone health and the development of innovative treatments to reduce mortality in osteoporosis patients. Through multidisciplinary collaborations, he aims to bridge clinical research with practical healthcare solutions, advancing the understanding and management of age-related diseases.

Conclusion

Dr. Chun-Feng Huang is an outstanding candidate for the Best Researcher Award. His prolific research output, leadership roles, and clinical impact demonstrate excellence and dedication. Addressing the suggested areas for improvement could further elevate his contributions, but his current achievements already position him as a leading figure in his field.

Publication Top Notes

Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach

Authors: CF Huang, ML Cheng, CM Fan, CY Hong, MS Shiao

Citations: 57

Year: 2013

Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial

Authors: WJ Lee, LN Peng, CH Lin, RC Chen, SZ Lin, CH Loh, SL Kao, TS Hung, …

Citations: 55

Year: 2021

Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes

Authors: YC Chen, YH Kao, CF Huang, CC Cheng, YJ Chen, SA Chen

Citations: 38

Year: 2010

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Authors: TW Tai, CF Huang, HK Huang, RS Yang, JF Chen, TT Cheng, FP Chen, …

Citations: 29

Year: 2023

Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study

Authors: TW Tai, CC Li, CF Huang, WP Chan, CH Wu

Citations: 24

Year: 2022

Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics

Authors: CF Huang, YC Chen, HI Yeh, SA Chen

Citations: 22

Year: 2012

Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis

Authors: CH Wu, WC Hung, L Chang, TT Tsai, YF Chang, EV McCloskey, NB Watts, …

Citations: 19

Year: 2020

Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients

Authors: CF Huang, MS Shiao, TY Mao

Citations: 17

Year: 2021

Detection of ventilatory thresholds using near-infrared spectroscopy with a polynomial regression model

Authors: CW Lin, CF Huang, JS Wang, LL Fu, TY Mao

Citations: 15

Year: 2020

First insights on value-based healthcare of elders using ICHOM older person standard set reporting

Luis Sobrevia | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Prof. Luis Sobrevia | Medicine and Dentistry | Best Researcher Award

Prof. Luis Sobrevia, Pontificia Universidad Católica de Chile, Chile

Prof. Luis Sobrevia is a distinguished Chilean physiologist with extensive academic and research credentials. He completed his BSc in Biological Sciences from Universidad del Bío-Bío, MSc in Physiological Sciences from Universidad de Concepción, and PhD in Physiology and Biomedicine from King’s College London. He has held postdoctoral training at King’s College London and earned a Diploma in University Teaching from Pontificia Universidad Católica de Chile (PUC). As a Fellow of The Physiological Society (UK) and the International Union of Physiological Sciences, he holds prominent academic positions worldwide, including at PUC, TecSalud in Mexico, and UNESP in Brazil. His research focuses on placental vascular dysfunction in pregnancy complications like gestational diabetes and obesity, studying pathways that affect maternal-fetal health. He has mentored numerous PhD and MSc students and collaborates globally on groundbreaking research. 🌍🔬

Publication Profile

Education

Prof. Luis Sobrevia holds a BSc Hons. in Biological Sciences (1986) from Universidad del Bío-Bío, Chile, and an MSc in Physiology (1990) from Universidad de Concepción, Chile. He earned his PhD in Physiology and Biomedicine (1996) at King’s College London, UK, followed by a postdoctoral fellowship there. Prof. Sobrevia has held academic positions globally, currently serving as a Distinguished Research Professor at Tecnológico de Monterrey, Mexico, and as an Honorary Professor in Australia, Spain, and Brazil. His extensive experience spans physiology, biomedicine, and university teaching, making significant contributions to obstetrics and biomedical sciences. 🏥📚

 

Research

Prof. Luis Sobrevia leads an extensive research group comprising PhD students from various global institutions, such as PUC Chile, U Talca, UNESP Brazil, and U Coimbra, Portugal. His team includes MSc and undergraduate students, along with technical research assistants like biochemist K Silva. The group hosts postdoctoral researchers, including A Grismaldo and MA Pascon. Collaborations span prestigious institutions like University Medical Centre Groningen, TecSalud, and Karolinska Institutet. As a thesis supervisor, Prof. Sobrevia has mentored 69 students across PhD, MSc, and undergraduate levels, focusing on physiology, biomedicine, and molecular biology. 🌍📚💡

 

Teaching Experience 🎓📚

Prof. Luis Sobrevia is a dedicated educator, teaching undergraduate courses in Medicine, Biology, Biochemistry, Nutrition, and Bioethics. He also mentors postgraduate students, including PhD, MSc, and medical specialization programs. His teaching spans top universities in Chile (PUC, UCH, UT, UA, UACH, UDEC) and internationally at institutions like UMCG (Netherlands), US (Spain), KCL (UK), AUT (New Zealand), UQCCR (Australia), UNESP (Brazil), and TecMonterrey (Mexico). His expertise covers topics such as gestational diabetes, fetal vascular dysfunction, cardiovascular pathophysiology, endothelial physiology, and insulin and adenosine signaling. 🌍🩺📖

 

Academic and Scientific Merit Recognitions 🌟🏅

Prof. Luis Sobrevia has earned numerous prestigious awards and appointments throughout his academic career. In 2024, he was nominated as a Corresponding Member of the Chilean Academy of Sciences and recognized for his contributions to internationalization by the Mexican Society of Physiological Sciences. He was also appointed Co-president of the Regional Focal Point for Latin America and the Caribbean (RFP-LAC) of the International Science Council (ISC) and Editor-in-Chief of Physiological Minireviews. His leadership extends to roles such as Regional Editor for The Journal of Physiology and member of international scientific committees, highlighting his significant global impact. 🌍📚💡

 

Publication Top Notes

  • Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells by GE Mann, DL Yudilevich, L Sobrevia, Physiological reviews 83 (1), 183-252, Cited by: 578, 2003 📚💉
  • A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration by C Salomon, MJ Torres, M Kobayashi, K Scholz-Romero, L Sobrevia, PloS one 9 (6), e98667, Cited by: 412, 2014 🤰🔬
  • Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis by C Salomon, J Ryan, L Sobrevia, M Kobayashi, K Ashman, M Mitchell, PloS one 8 (7), e68451, Cited by: 400, 2013 🌱💧
  • Oxidative stress: Normal pregnancy versus preeclampsia by DI Chiarello, C Abad, D Rojas, F Toledo, CM Vázquez, A Mate, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (2), 165354, Cited by: 325, 2020 🩸💔
  • Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes by C Salomon, M Kobayashi, K Ashman, L Sobrevia, MD Mitchell, GE Rice, PloS one 8 (11), e79636, Cited by: 213, 2013 🌍💫
  • Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia by L Sobrevia, GE Mann, Experimental Physiology: Translation and Integration 82 (3), 423-452, Cited by: 208, 1997 🧬🩺
  • Activation of L‐arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells by L Sobrevia, A Nadal, DL Yudilevich, GE Mann, The Journal of physiology 490 (3), 775-781, Cited by: 204, 1996 ⚡💡
  • Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy by SD Calligaris, M Lecanda, F Solis, M Ezquer, J Gutierrez, E Brandan, PloS one 8 (4), e60931, Cited by: 189, 2013 🍔❤️
  • Extracellular vesicles in obesity and diabetes mellitus by F Pardo, R Villalobos-Labra, B Sobrevia, F Toledo, L Sobrevia, Molecular aspects of medicine 60, 81-91, Cited by: 187, 2018 🧬🍩
  • Early activation of the p42/p44MAPK pathway mediates adenosine‐induced nitric oxide production in human endothelial cells: a novel calcium‐insensitive … by AW Wyatt, JR Steinert, CPD Wheeler‐Jones, AJ Morgan, D Sugden, The FASEB journal 16 (12), 1584-1594, Cited by: 155, 2002 🔬💡

 

 

Serhat Aras | Health Professions | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Serhat Aras | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Serhat Aras, University of Health Sciences Turkey, Turkey

Assoc. Prof. Dr. Serhat Aras is a nuclear physicist with a Ph.D. from Manisa Celal Bayar University, where he focused on Monte Carlo methods in dose calculations for prostate brachytherapy. He currently serves at the University of Health Sciences, Istanbul, specializing in medical imaging and radiological sciences. Dr. Aras has led research on the radiobiological effects of advanced radiation techniques in cancer treatments, including studies on breast and lung cancer. His teaching includes courses on radiologic imaging, radiation safety, and nuclear medicine. In 2023, he received an International Research Award in India. 🧪📡👨‍🏫

 

Publication Profile

Google Scholar


Academic Background

Dr. Aras completed his PhD in Nuclear Physics at Celal Bayar University, focusing on advanced methodologies for calculating patient doses in prostate brachytherapy using Monte Carlo simulations. His Master’s research also focused on dose distribution in brachytherapy, providing a solid foundation for his contributions to medical physics. His specialized education enhances his capacity to innovate in patient-specific dosimetry, an essential area in clinical radiotherapy.

Professional Experience

Dr. Aras serves in the Medical Imaging Techniques Program at Istanbul Health Sciences University. His roles have included Assistant Professor and Lecturer, where he has imparted his knowledge in courses such as Radiologic Imaging Physics, Radiation Safety, and Nuclear Medicine. His expertise in radiology and medical physics makes him an asset to the field, both in research and education, as he prepares future professionals in these highly technical fields.

Research Projects

Dr. Aras has led numerous research projects in radiobiology and oncology, demonstrating his commitment to advancing medical science. His projects include the study of radiobiological impacts on non-small cell lung cancer xenografts and the protective effects of melatonin and probiotics against radiation-induced tissue damage in experimental rat models. His role as a principal investigator in these studies reflects his leadership and research aptitude, focusing on innovative approaches to radiotherapy and radiation protection.

Awards and Recognition

Dr. Aras received the 2023 International Research Award from ISSN, India, which highlights his global research impact. This accolade, along with his publication record, underscores his contributions to nuclear and medical physics on an international level.

Conclusion

Assoc. Prof. Dr. Serhat Aras’s extensive research in medical imaging, radiotherapy, and radiobiological protection, combined with his teaching and leadership roles, makes him a suitable and commendable candidate for the Best Researcher Award. His contributions to nuclear physics applications in medicine reflect both a commitment to scientific advancement and a positive impact on clinical practices.

 

Publication Top Notes  

  • Dosimetric comparison of three-dimensional conformal radiotherapy (3D-CRT) and intensity modulated radiotherapy techniques (IMRT) with radiotherapy dose simulations for left breast cancer 💉 – Cited by: 41, Year: 2019
  • Dosimetric comparison of superflab and specially prepared bolus materials used in radiotherapy practice 📏 – Cited by: 27, Year: 2020
  • The role of melatonin on acute thyroid damage induced by high dose rate X-ray in head and neck radiotherapy 🌙 – Cited by: 12, Year: 2021
  • Radioprotective effect of melatonin against radiotherapy-induced cerebral cortex and cerebellum damage in rat 🐭 – Cited by: 11, Year: 2020
  • Radiobiological comparison of flattening filter (FF) and flattening filter free (FFF) beam in rat laryngeal tissue 🔬 – Cited by: 8, Year: 2020
  • Home care for mastectomy patients 🏥 – Cited by: 0, Year: 2008
  • A survey study of radiation protection awareness among radiology technicians in Mogadishu, Somalia 🌍 – Cited by: 7, Year: 2020
  • Thoracic re-irradiation for locally recurrent lung cancer 🫁 – Cited by: 5, Year: 2016
  • The dosimetric comparison and evaluation of helical tomotherapy, volumetric-modulated arc radiotherapy (VMAT), step-and-shoot and sliding window radiotherapy techniques in breast cancer 💻 – Cited by: 4, Year: 2022
  • Effect of Flattening Filter and Flattening Filter Free beams on radiotherapy-induced peripheral blood cell damage ⚗️ – Cited by: 4, Year: 2021

 

 

 

 

 

Claire Fontaine | Health Professions | Best Researcher Award

Published on by Global Academic Awards

Dr. Claire Fontaine | Health Professions | Best Researcher Award

Dr. Claire Fontaine, Technical University of Kenya, Kenya

Dr. Claire Fontaine is a junior doctor specializing in allergology at CHU Rennes. She earned her Doctorate in Medicine from the University of Rennes I in 2021, with a thesis on pediatric allergies to chlorhexidine 🌿. Her advanced studies include a DES in Allergology, with research on diazoxide desensitization in a young child with DRESS syndrome 🩺. Her professional path includes extensive hospital experience in allergology, pediatrics, dermatology, and internal medicine. Fluent in English and German 🌍, Dr. Fontaine also has a background in marketing and product innovation. Her interests lie in environmental sustainability, innovation, and music 🎶.

 

Education 📚

Dr. Fontaine holds a Doctorate in Medicine (2021) and a DES in Allergology from the University of Rennes I. Her thesis on “Immediate allergies to chlorhexidine: a series of pediatric cases” contributes significant insight into allergology, while her focus on diazoxide desensitization highlights her dedication to complex allergy cases in pediatrics. Her extensive academic foundation provides a solid basis for impactful research in allergology.

Professional Experience 🏥

Dr. Fontaine has held several roles within the institution, progressing from medical intern to a junior doctor. These positions have given her a diverse medical background, including stints in dermatology, pediatrics, and internal medicine, which add depth to her allergology expertise. Her years as an intern and doctor in various specialized departments demonstrate her commitment to healthcare and research in allergology.

Research Contributions 🧪

Dr. Fontaine’s thesis work on pediatric allergy cases and her research on the failure of diazoxide desensitization offer valuable insights into allergology. Her work adds to the body of knowledge in allergology, particularly concerning pediatric cases and drug-induced allergic reactions, which are relevant to advancing medical understanding and patient safety. These contributions reflect a robust research foundation in allergology.

Conclusion 🏆

Dr. Claire Fontaine’s robust academic training, clinical experience, and focused research on allergology-related challenges, particularly in pediatric and drug-allergy cases, make her a suitable candidate for the Best Researcher Award. Her dedication to allergology, combined with her valuable contributions to the field, reflect the qualities of a committed and innovative researcher.

 

Publication Top Notes

  • 📱 “Nobody sees it, nobody gets mad”: Social media, privacy, and personal responsibility among low-SES youth — Cited by 132 (2017)
  • 📰 How youth navigate the news landscape — Cited by 71 (2017)
  • 🎥 Youth video-making — Cited by 47 (2012)
  • 💬 Re-centering the role of care in young people’s multimodal literacies: A collaborative seeing approach — Cited by 21 (2015)
  • 📊 The myth of accountability: How data (mis) use is reinforcing the problems of public education — Cited by 15 (2016)
  • 📈 Clinical Data Mining With the Listening Guide: An Approach to Narrative Big Qual — Cited by 11 (2020)
  • 🏫 Spectrum of trust in data: Views of New York City parents navigating school choice — Cited by 5 (2018)
  • 🌐 Growing Up Online: Identity, Development and Agency in Networked Girlhoods — Cited by 3 (2015)